Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-21-050757

Chief Scientific Officer bought 1,163 shares at $3.62 ($4,210)

From the SEC's structured data for this filing

Trades in this filing

Blouse Grant E. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-09 Purchase : show line 1 in the form +1,163 $3.62 $4,210 2,917 D
Open-market purchases · 1,163 sh · avg $3.62 · $4,210
Loading xslF345X03/doc4.xml…